Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Gill Insider Profile
11 Followers
David Gill, Chief Financial Officer at EndoChoice Holdings, holds 44.33K shares in Evolus (Ticker: EOLS), holds 2.33K shares in Y-Mabs Therapeutics (Ticker: YMAB), holds 78.06K shares in Strongbridge Biopharma (Ticker: SBBP).
David Gill EndoChoice Holdings (GI)Chief Financial Officer
EndoChoice Holdings (GI)
Chief Financial Officer
Ranked #56,878 out of 98,624 Corporate Insiders
Profitable Transactions
6 out of 10 Profitable Transactions
Average Return
-2.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Gill holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Gill
David Gill's Trading History
EndoChoice Holdings
Nov 23, 2016
―
Uninformative Sell
1.31M
$1.14M
Evolus
Feb 09, 2024
Director
Uninformative Buy
―
$559.38K
Strata Skin Sciences
Nov 26, 2019
Director
Uninformative Buy
―
$26.52K
Y-Mabs Therapeutics
Jun 09, 2023
Director
Uninformative Buy
―
$38.42K
Strongbridge Biopharma
Oct 05, 2021
―
Uninformative Sell
36.59K
$156.12K
Melinta Therapeutics
May 30, 2018
―
Informative Buy
30.45K
$660.00
Ocugen
Aug 17, 2017
Director
Informative Buy
5.43K
$0.00
NxStage Medical
―
―
―
$223.26K
Lemaitre Vascular
―
Director
―
$454.44K
List of latest transactions for each holding click on a transaction to see David Gill's performance on stock
You May Also Like
David Gill insider profile FAQ
What is the percentage of profitable transactions made by David Gill?
The percentage of profitable transactions made by David Gill is 60%.
What is the average return per transaction made by David Gill?
The average return per transaction made by David Gill is -2.60%.
What stocks does David Gill hold?
David Gill holds: GI, EOLS, SSKN, YMAB, SBBP, MLNTQ, OCGN, NXTM, LMAT stocks.
What was David Gill’s latest transaction?
David Gill latest transaction was an Uninformative Buy of ―.
What was David Gill's most profitable transaction?
David Gill’s most profitable transaction was an Informative Buy of OCGN stock on August 17, 2017. The return on the trade was 48.70%.
What is David Gill's role in EndoChoice Holdings?
David Gill's role in EndoChoice Holdings is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.